Share on:
Join us at the European Buiatric Congress
On May 15th and 16th, the city of Nantes, France, will become a hub for cattle health professionals as it hosts the European Buiatrics Congress 2025, organized by the Société Nationale des Groupements Techniques Vétérinaires (SNGTV) and its Buiatric College.
Ceva is proud to participate in this key event on the buiatric calendar, and we invite you to visit us at our booth. With a strong focus on science and innovation, our team will present new data and practical insights on topics such as calf health, reproductive performance, Q Fever control, udder health and other important animal welfare topics. These contributions reflect our ongoing commitment to providing veterinarians and farmers with effective tools to enhance both animal well-being and farm sustainability.
By taking part in the EBC 2025, Ceva reinforces its dedication to advancing ruminant health through collaboration, innovation, and scientific excellence. Events like the EBC play a vital role in driving progress and building a more sustainable future for livestock farming.
Join us at our booth to explore the latest research and experience the special initiatives we’ve prepared for you.
Follow our Facebook page and don´t miss any of our activities during the congress.
Check the full list of oral presentations and posters from Ceva here:
ORAL PRESENTATIONS
May 15th
o Assessment of the impact of paromomycin at 150 mg/kg on gut microbiota in healthy calves. Damien Achard (Ceva). Room 1. 10h15 – 10h30.
o Q fever awareness among European ruminant farmers. Raphaël Guatteo (Oniris). Room 2. 15h45 – 16h00.
May 16th
o The economic impact of a systematic application of fertility programs in lactating dairy herds, an European perspective. Federico Randi (Ceva). Room 1. 9h45 – 10h00.
o Ketoprofen as the sole initial treatment for mild and moderate bovine mastitis: efficacy and antibiotic reduction. Volker Kromker. Room 1. 11h30 – 11h45.
POSTERS
32. Efficacy of a fixed combination of florfenicol and meloxicam to address lung lesions in veal calves with BRD; A. Lisuzzo.
39. The use of hepato-protectors during the transition period to manage hyperketonemia in dairy cows; A. Lisuzzo.
49. Q Fever in dairy cattle: comparison of prevalence at herd level according to clinical signs reported; Ph. Gisbert.
50. Fertility performances of lactating dairy cows submitted to timed artificial insemination or timed embryo transfer with fresh or frozen in vitro produced embryos in a seasonal pasture-based system; P. Pinho.
51. The Incidence and timing of pregnancy loss derived from timed artificial insemination or timed embryo transfer using fresh or frozen in vitro-produced embryos; F. Randi.
52. Coxiella burnetii seroprevalence evolution during the last 14 years in the Northwest of Spain; U. Yanez
53. Prevalences and effects on reproduction of Coxiella burnetii infection in dairy cattle farms in Galicia; U. Yanez.
62. Efficacy of an oral solution of paromomycin for the treatment of newborn calves with cryptosporidiosis in European farms; D. Achard.